Concepedia

Alessandra di Pietro

AD

Statistics

Publications

47

Citations

7.2K

H-Index

25

Active since

2008

Affiliations

Pfizer (Italy)(Current)

Pfizer (United States)

Institut Gustave Roussy

Dana-Farber Cancer Institute

Royal Marsden NHS Foundation Trust

Alessandra di Pietro is an author at Pfizer (Italy) specializing in oncology, medicine, and renal cell carcinoma.

Publications per year

2008–2024

47

Publications

47

Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Robert J. Motzer, Konstantin Penkov, John B.A.G. Haanen et al. · New England Journal of Medicine · 2019 · 2.5K citations · Full text

, , +6

Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma

Thomas Powles, Se Hoon Park, Éric Voog et al. · New England Journal of Medicine · 2020 · 1.5K citations · Full text

, , +12

Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial

Robert J. Motzer, Paul B. Robbins, Thomas Powles et al. · Nature Medicine · 2020 · 522 citations · Full text

, , +15

Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma

Toni K. Choueiri, Robert J. Motzer, Brian I. Rini et al. · Annals of Oncology · 2020 · 461 citations · Full text

, , +15

Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and dose-expansion, phase 1b trial

Toni K. Choueiri, James Larkin, Mototsugu Oya et al. · The Lancet Oncology · 2018 · 260 citations

, , +10

1–5 of 47